Literature DB >> 11871461

Effect of antimicrobial agents on the ecological balance of human microflora.

A Sullivan1, C Edlund, C E Nord.   

Abstract

The normal microflora acts as a barrier against colonisation of potentially pathogenic microorganisms and against overgrowth of already present opportunistic microorganisms. Control of growth of opportunistic microorganisms is termed colonisation resistance. Administration of antimicrobial agents, therapeutically or as prophylaxis, causes disturbances in the ecological balance between the host and the normal microflora. Most studies on the impact of antimicrobial agents on normal microflora have been carried out on the intestinal flora. Less is known on the effects on oropharyngeal, skin, and vaginal microflora. Disturbances in the microflora depend on the properties of the agents as well as of the absorption, route of elimination, and possible enzymatic inactivation and/or binding to faecal material of the agents. The clinically most common disturbances in the intestinal microflora are diarrhoea and fungal infections that usually cease after the end of treatment. A well-balanced microflora prevents establishment of resistant microbial strains. By using antimicrobial agents that do not disturb colonisation resistance, the risk of emergence and spread of resistant strains between patients and dissemination of resistant determinants between microorganisms is reduced. In this article, the potential ecological effects of administration of antimicrobial agents on the intestinal, oropharyngeal, and vaginal microflora are summarised. The review is based on clinical studies published during the past 10 years.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11871461     DOI: 10.1016/S1473-3099(01)00066-4

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  212 in total

1.  Emergence of resistant Klebsiella pneumoniae in the intestinal tract during successful treatment of Klebsiella pneumoniae lung infection in rats.

Authors:  Anne-Sylvie Kesteman; Agnès Perrin-Guyomard; Michel Laurentie; Pascal Sanders; Pierre-Louis Toutain; Alain Bousquet-Mélou
Journal:  Antimicrob Agents Chemother       Date:  2010-05-10       Impact factor: 5.191

2.  The optimal deployment of synergistic antibiotics: a control-theoretic approach.

Authors:  Rafael Peña-Miller; David Lähnemann; Hinrich Schulenburg; Martin Ackermann; Robert Beardmore
Journal:  J R Soc Interface       Date:  2012-05-23       Impact factor: 4.118

Review 3.  From structure to function: the ecology of host-associated microbial communities.

Authors:  Courtney J Robinson; Brendan J M Bohannan; Vincent B Young
Journal:  Microbiol Mol Biol Rev       Date:  2010-09       Impact factor: 11.056

4.  99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: induction and control of regulatory T cells in the gastrointestinal tract: consequences for local and peripheral immune responses.

Authors:  Y Belkaid; O Liesenfeld; R M Maizels
Journal:  Clin Exp Immunol       Date:  2010-04       Impact factor: 4.330

5.  Impact of empiric antibiotic regimen on bowel colonization in neonates with suspected early onset sepsis.

Authors:  U Parm; T Metsvaht; E Sepp; M-L Ilmoja; H Pisarev; M Pauskar; I Lutsar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-05-06       Impact factor: 3.267

Review 6.  Dentists, antibiotics and Clostridium difficile-associated disease.

Authors:  N Beacher; M P Sweeney; J Bagg
Journal:  Br Dent J       Date:  2015-09-25       Impact factor: 1.626

7.  The intestinal microbiota dysbiosis and Clostridium difficile infection: is there a relationship with inflammatory bowel disease?

Authors:  Justyna Bien; Vindhya Palagani; Przemyslaw Bozko
Journal:  Therap Adv Gastroenterol       Date:  2013-01       Impact factor: 4.409

8.  The correlation between Clostridium-difficile infection and human gut concentrations of Bacteroidetes phylum and clostridial species.

Authors:  E Goldberg; I Amir; M Zafran; U Gophna; Z Samra; S Pitlik; J Bishara
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-09-19       Impact factor: 3.267

9.  Clinical chorioamnionitis at term III: how well do clinical criteria perform in the identification of proven intra-amniotic infection?

Authors:  Roberto Romero; Piya Chaemsaithong; Steven J Korzeniewski; Juan P Kusanovic; Nikolina Docheva; Alicia Martinez-Varea; Ahmed I Ahmed; Bo Hyun Yoon; Sonia S Hassan; Tinnakorn Chaiworapongsa; Lami Yeo
Journal:  J Perinat Med       Date:  2016-01       Impact factor: 1.901

Review 10.  Clinical role of beta-lactam/beta-lactamase inhibitor combinations.

Authors:  Nelson Lee; Kwok-Yung Yuen; Cyrus R Kumana
Journal:  Drugs       Date:  2003       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.